The Reagan–Udall Foundation is a potential source of support for collaborations in development and regulatory science. Created in 2007 by the FDA Amendments Act of 2007, the Foundation was designed and given statutory authority to collaborate closely with FDA on scientific priorities to advance the agency’s mission to modernize medical, veterinary, food, and cosmetic product development, thereby accelerating innovation and enhancing the safety of medical products. The Foundation collaborates or contracts with stakeholders, such as FDA, university consortia, public– private partnerships, academia, nonprofits, and industry, to efficiently and effectively advance its goals and priorities. The Foundation is currently working on regulatory issues related to developing multiple drug regimens for tuberculosis as well as identifying common mechanisms of cardiotoxicity for oncology drugs.9
9 See http://www.focr.org/component/option,com_eventlist/Itemid,41/id,27/view,details/ (accessed December 14, 2001) and http://www.gatesfoundation.org/Grants-2011/Pages/Reagan-Udall-Foundation-OPP1027026.aspx (accessed December 14, 2001).